Zhejiang Xianju Pharmaceutical Company Overview
- Year Founded
-
2000
- Status
-
Public
- Employees
-
3,209
- Stock Symbol
-
002332
- Investments
-
8
- Share Price
-
$1.29
- (As of Friday Closing)
Zhejiang Xianju Pharmaceutical Company General Information
Description
Zhejiang Xianju Pharmaceutical Co Ltd is engaged in Research, development, production and sales of steroidal raw materials and preparations.
Contact Information
Website
www.xjpharma.comCorporate Office
- No.1, Xianyao Road
- Xianju County
- Taizhou, Jiangsu 317300
- China
Corporate Office
- No.1, Xianyao Road
- Xianju County
- Taizhou, Jiangsu 317300
- China
Zhejiang Xianju Pharmaceutical Company Stock Performance
As of 13-Nov-2026, Zhejiang Xianju Pharmaceutical Company’s stock price is $1.29. Its current market cap is $1.28B with 989M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.29 | $1.29 | $1.16 - $1.41 | $1.28B | 989M | 14.6M | $0.07 |
Zhejiang Xianju Pharmaceutical Company Financials Summary
As of 30-Sep-2026, Zhejiang Xianju Pharmaceutical Company has a trailing 12-month revenue of $560M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,130,980 | 1,131,644 | 1,190,866 | 1,576,548 |
| Revenue | 560,269 | 522,709 | 557,552 | 582,825 |
| EBITDA | 83,161 | 103,781 | 97,378 | 116,706 |
| Net Income | 67,488 | 62,525 | 55,352 | 79,589 |
| Total Assets | 1,056,070 | 1,037,467 | 958,835 | 986,490 |
| Total Debt | 31,785 | 28,786 | 8,076 | 30,945 |
Zhejiang Xianju Pharmaceutical Company Comparisons
Industry
Financing
Details
Zhejiang Xianju Pharmaceutical Company Competitors (3)
One of Zhejiang Xianju Pharmaceutical Company’s 3 competitors is Torrent Pharmaceuticals, a Corporation company based in Ahmedabad, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Corporation | Ahmedabad, India | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| Sanofi | Corporation | Gentilly, France |
Zhejiang Xianju Pharmaceutical Company Patents
Zhejiang Xianju Pharmaceutical Company Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026066417-A1 | New preparation method for α epoxy steroid compounds | Pending | 25-Sep-2024 | ||
| WO-2025195446-A1 | Inhalable pharmaceutical powder formulation and preparation method therefor | Pending | 20-Mar-2024 | ||
| CA-2568510-A1 | One-pot processes for preparing prednisolone derivatives | Active | 21-Nov-2006 | ||
| CA-2568510-C | One-pot processes for preparing prednisolone derivatives | Active | 21-Nov-2006 | ||
| US-20070117974-A1 | One-pot processes for preparing prednisolone derivatives | Inactive | 21-Jun-2005 | C07J71/00 |
Zhejiang Xianju Pharmaceutical Company Signals
Zhejiang Xianju Pharmaceutical Company Investments & Acquisitions (8)
Zhejiang Xianju Pharmaceutical Company’s most recent deal was a Early Stage VC with Yuhong Medical Technology for . The deal was made on 27-Dec-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Yuhong Medical Technology | 27-Dec-2023 | Early Stage VC | Medical Supplies | ||
| XHSynbio | 10-Mar-2023 | Later Stage VC | Specialty Chemicals | ||
| Cuize Medicine | 08-Jul-2019 | Joint Venture | Drug Discovery | ||
| Effechem | 14-Nov-2016 | Merger/Acquisition | Pharmaceuticals | ||
| Newchem | 09-Oct-2016 | Merger/Acquisition | Pharmaceuticals |
Zhejiang Xianju Pharmaceutical Company ESG
Risk Overview
Risk Rating
Updated September, 30, 2025
34.45 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,271
Rank
Percentile
Pharmaceuticals
Industry
of 908
Rank
Percentile
Pharmaceuticals
Subindustry
of 406
Rank
Percentile
Zhejiang Xianju Pharmaceutical Company Exits (1)
Zhejiang Xianju Pharmaceutical Company’s most recent exit was on 04-Sep-2003 from Zhejiang Xianle. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Zhejiang Xianle | 04-Sep-2003 | Completed |
|
Zhejiang Xianju Pharmaceutical Company Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Cuize Medicine | Hangzhou, China | 2019 | |
| Newchem | Milan, Italy | 1998 |
Zhejiang Xianju Pharmaceutical Company FAQs
-
When was Zhejiang Xianju Pharmaceutical Company founded?
Zhejiang Xianju Pharmaceutical Company was founded in 2000.
-
Where is Zhejiang Xianju Pharmaceutical Company headquartered?
Zhejiang Xianju Pharmaceutical Company is headquartered in Taizhou, China.
-
What is the size of Zhejiang Xianju Pharmaceutical Company?
Zhejiang Xianju Pharmaceutical Company has 3,209 total employees.
-
What industry is Zhejiang Xianju Pharmaceutical Company in?
Zhejiang Xianju Pharmaceutical Company’s primary industry is Pharmaceuticals.
-
Is Zhejiang Xianju Pharmaceutical Company a private or public company?
Zhejiang Xianju Pharmaceutical Company is a Public company.
-
What is Zhejiang Xianju Pharmaceutical Company’s stock symbol?
The ticker symbol for Zhejiang Xianju Pharmaceutical Company is 002332.
-
What is the current stock price of Zhejiang Xianju Pharmaceutical Company?
As of 13-Nov-2026 the stock price of Zhejiang Xianju Pharmaceutical Company is $1.29.
-
What is the current market cap of Zhejiang Xianju Pharmaceutical Company?
The current market capitalization of Zhejiang Xianju Pharmaceutical Company is $1.28B.
-
What is Zhejiang Xianju Pharmaceutical Company’s current revenue?
The trailing twelve month revenue for Zhejiang Xianju Pharmaceutical Company is $560M.
-
Who are Zhejiang Xianju Pharmaceutical Company’s competitors?
Torrent Pharmaceuticals, Novartis, and Sanofi are competitors of Zhejiang Xianju Pharmaceutical Company.
-
What is Zhejiang Xianju Pharmaceutical Company’s annual earnings per share (EPS)?
Zhejiang Xianju Pharmaceutical Company’s EPS for 12 months was $0.07.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process